Categorizing Risks within Barrett's Esophagus To Guide Surveillance and Interception; Suggesting a New Framework
Open Access
- 1 June 2023
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 16 (6) , 313-320
Abstract
Barrett's esophagus is a precancerous condition that can progress in a stepwise manner to dysplasia and eventually esophageal adenocarcinoma (EAC). Once diagnosed, patients with Barrett's esophagus are kept on surveillance to detect progression so that timely intervention can occur with endoscopic therapy. Several demographic and clinical risk factors are known to increase progression toward EAC, such as longer Barrett's segments, and these patients are kept on tighter surveillance. While p53 IHC has been advocated as an adjunct to histopathologic diagnosis, use of this biomarker is variable, and no other molecular factors are currently applied. Given the new evidence available, it is time to consider whether other risk factors or tools could be applied in clinical practice to decide on closer or attenuated surveillance. In this commentary, we summarize the most relevant risk factors for Barrett's esophagus progression, highlight the most promising novel risk stratification tools—including nonendoscopic triage and commercial biomarker panels, and propose a new framework suggesting how to incorporate risk stratification into clinical practice.Keywords
This publication has 45 references indexed in Scilit:
- ACG Clinical Guideline: Diagnosis and Management of Barrett’s EsophagusAmerican Journal of Gastroenterology, 2016
- Epidemiology of Barrett’s Esophagus and Esophageal AdenocarcinomaGastroenterology Clinics of North America, 2015
- Central Adiposity Is Associated With Increased Risk of Esophageal Inflammation, Metaplasia, and Adenocarcinoma: A Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology, 2013
- British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagusGut, 2013
- Cigarette smoking is a modifiable risk factor for Barrett's oesophagusUnited European Gastroenterology Journal, 2013
- Persistence of Nondysplastic Barrett's Esophagus Identifies Patients at Lower Risk for Esophageal Adenocarcinoma: Results From a Large Multicenter CohortGastroenterology, 2013
- Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagusGut, 2012
- Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett's oesophagus: a prospective, international, randomised controlled trialGut, 2012
- Barrett’s dysplasia and the Vienna classification: reproducibility, prediction of progression and impact of consensus reporting and p53 immunohistochemistryHistopathology, 2009
- Racial and Ethnic Disparities in the Prevalence of Barrett’s Esophagus Among Patients Who Undergo Upper EndoscopyClinical Gastroenterology and Hepatology, 2008